GLPBio

Signaling Pathways

Research Area, Signaling Pathways | GlpBio Life Science Products Suppliers

Read More about this category

The antibody-drug conjugate (ADC), a humanized or human monoclonal antibody conjugated with highly cytotoxic small molecules (payloads) through chemical linkers, is a novel therapeutic format and has great potential to make a paradigm shift in cancer chemotherapy. The three components of the ADC together give rise to a powerful oncolytic agent capable of delivering normally intolerable cytotoxins directly to cancer cells, which then internalize and release the cell-destroying drugs. At present, two ADCs, Adcetris and Kadcyla, have received regulatory approval with >40 others in clinical development.

ADCs are administered intravenously in order to prevent the mAb from being destroyed by gastric acids and proteolytic enzymes. The mAb component of the ADC enables it to circulate in the bloodstream until it finds and binds to tumor-specific cell surface antigens present on target cancer cells. Linker chemistry is an important determinant of the safety, specificity, potency and activity of ADCs. Linkers are designed to be stable in the blood stream (to conform to the increased circulation time of mAbs) and labile at the cancer site to allow rapid release of the cytotoxic drug. First generation ADCs made use of early cytotoxins such as the anthracycline, doxorubicin or the anti-metabolite/antifolate agent, methotrexate. Current cytotoxins have far greater potency and can be divided into three main groups: auristatins, maytansines and calicheamicins.

The development of site-specific conjugation methodologies for constructing homogeneous ADCs is an especially promising path to improving ADC design, which will open the way for novel cancer therapeutics.

References:

[1] Tsuchikama K, et al. Protein Cell. 2016 Oct 14. DOI:10.1007/s13238-016-0323-0.

[2] Peters C, et al. Biosci Rep. 2015 Jun 12;35(4). pii: e00225. doi: 10.1042/BSR20150089.

Research Areas

Products Related to Signaling Pathways(39835)

  • GC91829 structure
    GC91829Acriflavine Mixture
    Purity: >95.00%

    Acriflavine mixture is a mixture of proflavine, acriflavine, side-methylated proflavine, and side-methylated acriflavine.

  • GC91841 structure
    GC91841Mca-VDQVDGW-K(Dnp)-NH2 (acetate)
    Purity: >95.00%

    Mca-VDQVDGW-K(Dnp)-NH2 is a substrate for caspase-7.

  • GC91849 structure
    GC91849Autocamtide-2-related Inhibitory Peptide (trifluoroacetate salt)
    Purity: >95.00%

    Autocamtide-2-related inhibitory peptide is a calmodulin-dependent protein kinase II (CaMKII) inhibitor (IC50 = 40 nM) that was designed based on the sequence around the autophosphorylation site (Thr286/Thr287) in the autoinhibitory domain of the protein kinase.

  • GC91851 structure
    GC91851Malantide (trifluoroacetate salt)
    Purity: >98.00%

    Malantide is a synthetic peptide derived from the β-subunit of human phosphorylase kinase and is a fluorescent substrate for PKA and PKC.

  • GC91852 structure
    GC91852NFF-3 (trifluoroacetate salt)
    Purity: >95.00%

    NFF-3 is a fluorogenic substrate of matrix metalloproteinases (MMPs).

  • GC91857 structure
    GC91857Kdo2-Lipid A (sodium salt)

    Kdo2-Lipid A is the active component of LPS.

  • GC91866 structure
    GC91866Apelin-36 (trifluoroacetate salt)
    Purity: >95.00%

    The apelin gene encodes a preproprotein that is processed to generate a variety of bioactive peptides, including those having 36, 17, or 13 amino acids (apelin-36, apelin-17, and apelin-13, respectively).

  • GC91874 structure
    GC91874Polysarcosine20
    Purity: >90.00%

    Polysarcosine20 est un polymère hydrophile fonctionnalisé par aminé.

  • GC91884 structure
    GC91884DSPE-PEG(2000)-Mannose
    CAS: 1829524-73-3
    Purity: >98.00%

    DSPE-PEG(2000)-Mannose a été utilisé pour la préparation de liposomes et de Micelles mixtes pour la livraison d'agents anticancéreux à Tam, les macrophages associés à la tumeur, in vitro et in vivo.

  • GC91887 structure
    GC91887Methyl Salicylate-d4
    CAS: 1219802-12-6
    Purity: >99.00%

    Methyl Salicylate-d4 est destiné à être utilisé comme étalon interne pour la quantification du salicylate de méthyle par GC- ou LC-MS.

  • GC91889 structure
    GC91889L-Tyrosine (sodium salt hydrate)
    Purity: >98.00%

    L-Tyrosine (sodium salt hydrate) est un acide aminé conditionnellement essentiel.

  • GC91898 structure
    GC91898BI SF3 (hydrochloride)
    CAS: 1801257-24-8
    Purity: >95.00%

    BI SF3 (hydrochloride) est un intermédiaire synthétique.

  • GC91899 structure
    GC91899Carmustine-d8
    Purity: >99.00%

    Carmustine-d8 destiné à être utilisé comme étalon interne pour la quantification de la carmustine en chromatographie gazeuse ou en chromatographie liquide - spectrométrie de masse.

  • GC91904 structure
    GC91904CNBSF
    CAS: 3829-23-0

    CNBSF est un inhibiteur irréversible de glutathion s-transférase π 1-1 (GSTP1-1) et GST α 1-1 (GSTA1; Ci50 = 21 et 1,4 μM, respectivement).

  • GC91906 structure
    GC91906(R)-AS-1
    CAS: 2506367-95-7
    Purity: >95.00%

    (R)-AS-1 est un modulateur allostérique positif du transporteur d'acides aminés excitateur 2 eaat2; EC50 = 11 nm dans le test d'absorption du glutamate.

  • GC91909 structure
    GC91909Fenoprofen-13C6 (sodium salt hydrate)
    CAS: 2687960-29-6
    Purity: >98.00%

    Fenoprofen-13C6 (sodium salt hydrate) destiné à être utilisé comme étalon interne pour la quantification du fénoprofène par GC ou LC - MS.

  • GC91910 structure
    GC91910Ferroptosis Inhibitor D1
    Purity: >98.00%

    Ferroptosis Inhibitor D1 est un éliminateur de radicaux libres et un inhibiteur de l'affaissement du fer.

  • GC91911 structure
    GC91911Napirimus
    CAS: 70696-66-1
    Purity: >95.00%

    Napirimus est un immunosuppresseur.

  • GC91913 structure
    GC91913NS 3861
    CAS: 216853-59-7
    Purity: >98.00%

    NS 3861 est un agoniste neuronal nicotinique du récepteur de l’acétylcholine (nAChR).

  • GC91914 structure
    GC91914MSH Release-Inhibiting Factor (trifluoroacetate salt)
    Purity: >95.00%

    MSH Release-Inhibiting Factor (trifluoroacetate salt) (MSH-R-IF) est un tripeptide hypothalamique qui se lie au striatum du rat (Kd = 4,69 nM) et a diverses activités biologiques.

  • GC91915 structure
    GC91915ZG-2033
    CAS: 2685739-28-8
    Purity: >98.00%

    ZG-2033 est un agoniste du facteur hypoxia-inducible 2α (HIF-2α).

  • GC91919 structure
    GC91919Pro-GA
    CAS: 2222067-12-9

    Pro-GA est une forme Prodrogue de n - glutaryl - L - Alanine et un inhibiteur de la gamma - glutamyl cyclotransférase (ggct), une enzyme impliquée dans le métabolisme du glutathion.

  • GC91920 structure
    GC91920Rhein-13C6
    Purity: >95.00%

    Rhein-13C6 destiné à être utilisé comme étalon interne pour la quantification de l'acide rhubanoïque par GC ou LC - MS.

  • GC91921 structure
    GC91921Fenclofenac
    CAS: 34645-84-6
    Purity: >95.00%

    Fenclofenac est un anti - inflammatoire non stéroïdien (ains) et un inhibiteur de la Cox (IC50 de 7 et 4 μm pour Cox - 1 et Cox - 2, respectivement).